Hepatitis C Virus (HCV) (Whole Blood/Serum/Plasma) Rapid Test Device

Description

Hepatitis C Virus Rapid Test Device (Whole Blood/Serum/Plasma) 20 Tests

Hepatitis C Virus is a small, enveloped, positive-sense, single-stranded RNA Virus. HCV is now known to be the use only. major cause of parenterally transmitted non-A, non-B hepatitis. Antibody to HCV is found in over 80% of patients with well-documented non-A, non-B hepatitis. Conventional methods fail to isolate the virus in cell culture or visualize it by electron microscope. Cloning the viral genome has made it possible to develop serologic assays that use recombinant antigens.1,2 Compared to the first-generation HCV EIAs using single recombinant antigen, multiple antigens using recombinant protein and/or synthetic peptides have been added in new serologic tests to avoid nonspecific cross-reactivity and to increase the sensitivity of the HCV antibody tests. 3, 4

The HCV Rapid Test Device (Whole Blood/Serum/ Plasma) is a rapid test to qualitatively detect the presence of antibodies to HCV in whole blood, serum or plasma specimen. The test utilizes a combination of protein A coated particles and recombinant HCV proteins to selectively detect antibody to HCV in whole blood, serum or plasma. The recombinant HCV proteins used in the test kit are encoded by the genes for both structural (nucleocapsid) and non-structural proteins.